Abram Rabinowitz
Cardiovascular Disease · San Antonio, TXNPI 1780684050
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,800 of the $16,127 with a category attached, or 85.6%. W. L. Gore & Associates, Inc. accounts for 85.6% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $11,152 and has fallen 98.7% since, to $140 in 2021.
Across 65 payments — averaging $248.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$14K
- Abbott$2K
- Actelion Pharmaceuticals US, Inc.$176
- Abiomed$140
- Bayer$102
- Biotronik Inc.$53
- plus $197 from 8 others
Across 9 payments — averaging $12,487 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$112K
What the payments were for
- Speaking & faculty fees$13,80086%
- Travel & lodging$1,0897%
- Food & beverage$1,2388%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 3 | $13,800 |
| Abbott | 27 | $1,660 |
| Actelion Pharmaceuticals US, Inc. | 13 | $176 |
| Abiomed | 1 | $140 |
| Bayer | 6 | $102 |
| Biotronik Inc. | 1 | $53 |
| Amgen | 3 | $50 |
| Novartis | 3 | $41 |
| Johnson & Johnson | 3 | $28 |
| Boehringer Ingelheim | 1 | $18 |
| United Therapeutics Corporation | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
| Chiesi USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CARDIOFORM Septal Occluder$13,800
- Xience V coronary stent system$1,187
- Impella$140
How this compares
$16,127 in reported general payments places this provider in the 85th percentile of 1,515 cardiovascular disease providers in Texas.
Other cardiovascular disease in San Antonio
- Chandrasekhar KunavarapuSan Antonio$405K
- Eric StockerSan Antonio$229K
- Mark ColliganSan Antonio$129K
- Manoj PandaySan Antonio$119K
- Ramin Farzaneh-FarDallas$17.1M
- John OsborneGrapevine$1.3M
- Darren McGuireDallas$1.2M
- Peter McCulloughDallas$664K
- Ann NavarDallas$616K
- Biykem BozkurtHouston$606K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.